Better Deals and Lower Prices Act

House Bill

H.R. 4846

119th Congress

Better Deals and Lower Prices Act

In Committee

Introduced:Sep 11, 2025

Primary Sponsor

Frank D. Lucas

Representative

Republican

OK-3

Cosponsors

0

Quick Stats

Policy Area

Taxation

Summary

This bill would require pharmacy benefit managers (PBMs), companies that manage drug benefits for insurance plans, to report details about their operations to the government. This includes information on how much they receive from drug companies and how much the insurance plans spend on drugs.

Latest Action

Referred to the Subcommittee on Health.

SponsorFrank D. Lucas (R-OK)

Introduced9/11/2025

StatusReferred to the Subcommittee on Health.

ChamberHouse

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Better Deals and Lower Prices Act

This bill would require pharmacy benefit managers (PBMs), companies that manage drug benefits for insurance plans, to report details about their operations to the government. This includes information on how much they receive from drug companies and how much t

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill would require pharmacy benefit managers (PBMs), companies that manage drug benefits for insurance plans, to report details about their operations to the government. This includes information on how much they receive from drug companies and how much the insurance plans spend on drugs.

Bill Number: 4846
Sponsor: Frank D. Lucas (R-OK)
Introduced: 9/11/2025
Status: Referred to the Subcommittee on Health.
Policy Area: Taxation

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Better Deals and Lower Prices Act
Bill Number: 4846
Sponsor: Frank D. Lucas (R-OK)
Status: Referred to the Subcommittee on Health.
Introduced: 9/11/2025
Summary: This bill would require pharmacy benefit managers (PBMs), companies that manage drug benefits for insurance plans, to report details about their operations to the government. This includes information on how much they receive from drug companies and how much the insurance plans spend on drugs.

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill would require pharmacy benefit managers (PBMs), companies that manage drug benefits for insurance plans, to report details about their operations to the government. This includes information on how much they receive from drug companies and how much the insurance plans spend on drugs.

Last updated: 12/29/2025

Official Summary

Congressional Research Service summary

Better Deals and Lower Prices ActThis bill establishes reporting requirements for pharmacy benefit managers (PBMs) with respect to services provided to health insurance plans.First, PBMs must report annually to the plan sponsor certain information about the PBM's services, including the amount of prescription drug copayment assistance funded by drug manufacturers, a list of covered drugs billed under the plan during the reporting period, and the total gross and net spending by the health plan on prescription drugs during the reporting period. PBMs also must submit specified elements of the report (e.g., the total gross spending on prescription drugs) to the Government Accountability Office (GAO). The report must comply with the privacy requirements under the Health Insurance Portability and Accountability Act of 1996.The bill establishes civil penalties for violations of these requirements and provides for enforcement by the appropriate agencies.GAO must report on the pharmacy networks of plans or PBMs, including whether such networks under common ownership with the plans or PBMs are designed to encourage plan enrollees to use network pharmacies over other pharmacies.

Key Points

Main provisions of the bill

PBMs must report annually to insurance plans on their services, including the amount of drug copay assistance from manufacturers and total spending on drugs
PBMs must submit key financial data to the Government Accountability Office
The bill establishes penalties for PBMs that violate the reporting requirements
The GAO must study whether PBM pharmacy networks are designed to steer patients to certain pharmacies

How This Impacts Americans

Potential effects on citizens and communities

This bill would increase transparency around the role and finances of PBMs, which play a major part in determining drug prices and costs for consumers. It could shed light on potential conflicts of interest or anti-competitive practices. Consumers, insurance plans, and policymakers would gain more insight into how the PBM industry operates.

Policy Areas

Primary Policy Area

Taxation

Related Subjects

Business records

Civil actions and liability

Employee benefits and pensions

Government information and archives

Government studies and investigations

Health care costs and insurance

Health information and medical records

Prescription drugs

Right of privacy

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

4846, 119th Congress (2025). "Better Deals and Lower Prices Act". Source: Voter's Right Platform. https://votersright.org/bills/118-hr-4846

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.

Related Bills in Taxation

HR 1827

Child Care Availability and Affordability Act

Referred to the House Committee on Ways and Means.

HR 2927

All-Americans Tax Relief Act of 2025

Referred to the House Committee on Ways and Means.

HR 2918

Family Business Legacy Act of 2025

Referred to the House Committee on Ways and Means.

S 1481

LOCAL Infrastructure Act

Read twice and referred to the Committee on Finance.